What Makes the Secukinumab Market a Key Player in Biologics for...

agregó una foto Other

2026-03-31 03:58:20 -

What Makes the Secukinumab Market a Key Player in Biologics for Autoimmune Disorders?

The Secukinumab Market is poised for steady growth, projected to reach USD 8,445 Million by 2034 from USD 5,389 Million in 2023 at a CAGR of 4.3% from 2024 to 2030. Its targeted mechanism and effectiveness in managing psoriasis, psoriatic arthritis, and ankylosing spondylitis are driving its adoption worldwide. The Secukinumab Market Analysis 2024-2030 shows the Asia-Pacific region as a...

0 Commentarios 0 Acciones 82 Views 0 Vista previa